CLIA lab

CLIA 14D1033165: Osco Drug #3464

Grayslake, IL. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 14D1033165 belongs to Osco Drug #3464 in Grayslake, IL.

Certificate of Waiver, effective September 12, 2025, expires September 11, 2027.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
September 12, 2025
Certificate expiration
September 11, 2027
Status in the CMS file
Active (termination code 00)
Original participation date
November 5, 2004
Facility type
Pharmacy
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
14D1033165
Lab name
Osco Drug #3464
Address
885 E Belvidere Road, Grayslake, IL 60030
Phone
(847) 543-9082
Fax
(847) 543-9124

Annual test volume the lab reported

Waived tests
1,000

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Grayslake, IL

Related

Questions

What is the CLIA number for Osco Drug #3464 in Grayslake?

14D1033165, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Osco Drug #3464 hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 14D1033165 expire?

The CMS file lists September 11, 2027 as the certificate expiration date; the certificate took effect September 12, 2025.

Try it on your own data today.

Free to start. Most teams are using it the same day.